Advertisement

Evaluation of a Diabetes Management System based on Practice Guidelines, Integrated Care and Continuous Quality Management in a Federal State of Germany: a Population-based Approach to Health Care Research

  1. Ulrike Rothe, MD (u_rothe{at}imib.med.tu-dresden.de)1,
  2. Gabriele Müller, MPH1,
  3. Peter EH Schwarz, MD2,
  4. Martin Seifert1,
  5. Hildebrand Kunath, PhD MD1,
  6. Rainer Koch, PhD1,
  7. Sybille Bergmann, PhD3,
  8. Ulrich Julius, PhD MD2,
  9. Stefan R Bornstein, PhD MD2,
  10. Markolf Hanefeld, PhD MD4 and
  11. Jan Schulze, PhD MD2,,5
  1. 1Institute for Medical Informatics and Biometrics and
  2. 2Department of Medicine III and
  3. 3Institute for Clinical Chemistry and Laboratory Medicine, Medical Faculty Carl Gustav Carus, Technical University of Dresden (TUD)
  4. 4Centre for Clinical Studies, Society for Science and Technology Transfer, TUD
  5. 5Saxon Chamber of Physicians

    Abstract

    Objective: The aim was to evaluate the Saxon Diabetes Management Program (SDMP) which is based on integrated practice guidelines, shared care and integrated quality management. The SDMP was implemented into diabetes contracts between health insurances, GPs and diabetes specialised practitioners (DSPs) unified in the Saxon association of Statutory Health Insurance Physicians.

    Research Design And Methods: The evaluation of the SDMP in Germany represents a real world study by using clinical data collected from participating physicians. Between 2000 and 2002 all DSPs and about 75% of the GPs in Saxony participated. Finally 291,771 patients were included in the SDMP. Cross-sectional data were evaluated at the beginning of 2000 (group A1) and at the end of 2002 (group A2). A subcohort of 105,204 patients was followed up over a period of three years (group B).

    Results: The state-wide implementation of the SDMP resulted in a change of therapeutic practice and in better cooperation. The median HbA1c at the time of referral to DSPs decreased from 8.5% to 7.5% and so the overall mean did. At the end, 78% and 61% of group B achieved the targets for HbA1c and BP, respectively recommended by the guidelines compared to 69% and 50% at baseline. Poorly controlled patients benefited the most. Pre-existing regional differences were aligned.

    Conclusions: An integrated care disease management with practicable integrated quality management including collaboration between GPs and specialist services is a significant innovation of chronic care management and an efficient way to improve diabetes care continuously.

    Footnotes

      • Received May 3, 2007.
      • Accepted January 25, 2008.

    This Article

    1. Diabetes Care March 10, 2008
    1. All Versions of this Article:
      1. dc07-0858v1
      2. 31/5/863 most recent
    Advertisement